학술논문

An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin’s lymphoma
Document Type
Article
Source
In Annals of Oncology July 2011 22(7):1622-1627
Subject
Language
ISSN
0923-7534